Article Information
PubMed
Print ISSN
Online ISSN
History
- Received June 14, 2004
- Accepted November 5, 2004
- Published online January 19, 2005.
Article Versions
- Earlier version (November 5, 2004 - 12:42).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Smitha Antony,
- Glenda Kohlhagen,
- Keli Agama,
- Muthusamy Jayaraman,
- Shousong Cao,
- Farukh A. Durrani,
- Youcef M. Rustum,
- Mark Cushman and
- Yves Pommier
- Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (S.A., G.K., K.A., Y.P.); Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana (M.J., M.C.); and Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York (S.C., F.D., Y.M.R.)
- Address correspondence to:
Dr. Yves Pommier, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, 37 Convent Dr., Bldg 37, Rm 5068, National Institutes of Health, Bethesda, MD 20892-4255. E-mail: pommier{at}nih.gov
Statistics from Altmetric.com
Article usage
In this issue
Cellular Topoisomerase I Inhibition and Antiproliferative Activity by MJ-III-65 (NSC 706744), an Indenoisoquinoline Topoisomerase I Poison
